SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nanobac Pharmaceuticals Inc – ‘10KSB’ for 12/31/05 – EX-32.2

On:  Friday, 3/31/06, at 4:52pm ET   ·   For:  12/31/05   ·   Accession #:  1144204-6-13205   ·   File #:  33-80612

Previous ‘10KSB’:  ‘10KSB/A’ on 8/16/05 for 12/31/04   ·   Next:  ‘10KSB’ on 5/4/07 for 12/31/06   ·   Latest:  ‘10KSB’ on 4/15/08 for 12/31/07

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/31/06  Nanobac Pharmaceuticals Inc       10KSB      12/31/05    7:2.2M                                   Vintage/FA

Annual Report — Small Business   —   Form 10-KSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10KSB       Annual Report -- Small Business                     HTML    764K 
 2: EX-10.26    Material Contract                                   HTML      5K 
 3: EX-21.1     Subsidiaries of the Registrant                      HTML      7K 
 4: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 5: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 6: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 
 7: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 


EX-32.2   —   Certification per Sarbanes-Oxley Act (Section 906)


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




EXHIBIT 32.2

CERTIFICATION
Pursuant to 18 United States Code Section 1350

The undersigned hereby certifies that the Annual Report on Form 10-KSB for the year ended December 31, 2005 of Nanobac Pharmaceuticals, Incorporated (the "Company") filed with the Securities and Exchange Commission on the date hereof fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ John D Stanton

John D Stanton
Chief Financial Officer

 
A signed original of this written statement required by Section 906 has been provided to Nanobac Pharmaceuticals, Incorporated and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
 
 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10KSB’ Filing    Date    Other Filings
Filed on:3/31/0610QSB
3/30/068-K
For Period End:12/31/05
 List all Filings 
Top
Filing Submission 0001144204-06-013205   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 11:02:01.1am ET